What Is the Difference Between a CT Scan and a CT Enterography?

A standard CT scan of the abdomen and a CT enterography (often called CTE) use the same basic machine, but they are set up very differently and answer different clinical questions. The critical distinction lies in how the bowel is prepared before scanning and how the images are timed to capture detail in the intestinal wall. A routine abdominal CT is a general-purpose look at everything from the liver to the pelvis, while CTE is specifically engineered to reveal problems inside the small bowel, a stretch of intestine that standard CT handles poorly. If your doctor ordered one over the other, understanding why can help you make sense of both the prep and the results.

How the Prep Sets Them Apart

The single biggest practical difference you’ll notice is what you drink beforehand. For a routine abdominal CT, you typically swallow a “positive” oral contrast agent, a dense liquid containing barium or iodine that shows up bright white on the scan. This fills the bowel with a high-density material that helps radiologists distinguish loops of intestine from surrounding tissue. It works well for spotting things like abscesses, enlarged lymph nodes, and organ abnormalities, but it has a drawback: because the liquid inside the bowel glows white, the bowel wall itself gets washed out. You can’t see subtle thickening or enhanced blood flow in the intestinal lining when everything nearby is already bright.

CTE flips this approach. Instead of positive contrast, you drink a large volume of a “neutral” oral agent, something with a density close to water. Common choices include dilute barium suspensions, polyethylene glycol solutions, mannitol, or even plain water mixed with a flavoring agent. The goal is to balloon the small bowel open with fluid that stays dark on the scan. Against that dark background, the bowel wall stands out clearly, and when intravenous contrast is injected, any inflammation or abnormal blood supply in the wall lights up in sharp relief. A head-to-head comparison found that neutral oral contrast produced significantly better bowel distension, more uniform luminal content, and clearer delineation of the bowel wall compared with positive oral contrast, resulting in higher overall image quality.¹

The volume matters, too. A standard CT might ask you to drink a cup or two of contrast. CTE protocols often call for 1,000 to 2,000 mL consumed over roughly an hour before the scan. That’s a lot of liquid, and it can be uncomfortable. One trial found that patients given the larger 2,000 mL volume reported side effects like nausea, diarrhea, and abdominal pain more often than those given 1,000 mL.² When researchers compared different prep drinks head to head, water and methylcellulose had the fewest side effects overall, while polyethylene glycol was rated the most difficult to drink and least preferred by volunteers.³ Larger volumes of flavored beverages and low-density barium suspensions also caused more cramping and diarrhea, and subjects were most willing to repeat the protocol when asked to drink just 1,000 mL of a flavored beverage or water.⁴

Why Intravenous Contrast Timing Is Different

Both a standard abdominal CT and CTE typically use intravenous (IV) contrast, the dye injected into your arm that helps organs and blood vessels show up on the scan. But the timing of when the scanner fires after that injection is tailored differently. A routine CT of the abdomen is often acquired in the “portal venous phase,” roughly 60 to 70 seconds after the injection starts, which is ideal for evaluating solid organs like the liver, spleen, and kidneys. Some protocols add an earlier arterial-phase pass for specific questions.

CTE uses what’s called the “enteric phase,” typically acquired about 50 to 70 seconds after IV contrast begins. This window is optimized for the moment when contrast has soaked into the bowel wall enough to make inflammation, masses, and vascular abnormalities visible. Research has shown that enteric-phase images provide better visibility of bowel wall enhancement than arterial-phase images alone, with no major difference between a 40-second and 70-second delay for spotting active Crohn’s disease inflammation, though scanning closer to 70 seconds also gives a better look at the liver and other solid organs.⁵ It’s a small technical nuance, but it means the CTE protocol is calibrated to catch bowel-specific pathology that a general-purpose scan might underplay.

What CTE Reveals That a Standard CT Often Misses

A routine CT is quite good at picking up things happening outside the bowel wall: abscesses, free fluid, enlarged lymph nodes, kidney stones, liver lesions, and other big-picture abdominal problems. It can also detect severe bowel obstruction or obvious masses. But subtle changes in the bowel wall itself, the kind that define early or moderate inflammatory bowel disease, often slip through.

CTE was developed specifically to address this gap. By combining the improved resolution of modern multi-detector CT scanners with large volumes of neutral oral contrast, it lets radiologists see the bowel wall in a way that routine CT cannot. A review of over 700 CTE cases found that the technique clearly depicts small bowel inflammation by showing wall thickening, mural hyperenhancement (the wall soaking up more contrast than normal), a layered or stratified appearance of the wall, engorged blood vessels around the intestine (sometimes called the “comb sign”), and surrounding inflammatory changes in the fat and tissue near the bowel.⁶ Standard CT had mainly been used to find the complications of Crohn’s disease, like fistulas and abscesses, rather than the inflammation driving the disease itself.

This distinction is clinically meaningful. Crohn’s disease produces a characteristic pattern on CTE: long segments of asymmetric wall thickening, fibrofatty proliferation (fat wrapping around the outside of the bowel), increased blood vessel visibility in the mesentery, and fistula tracts connecting loops of bowel or running toward the skin.⁷ These findings allow gastroenterologists to gauge disease severity, decide whether to escalate medications, and plan surgery if needed.

Who Needs CTE and Who Needs a Standard CT

Your doctor’s choice between these two exams comes down to what question they’re trying to answer. A standard abdominal CT is the workhorse for acute situations: appendicitis, diverticulitis, kidney stones, trauma, suspected bowel obstruction from adhesions, or looking for cancer spread across the abdomen. It’s fast, widely available, and doesn’t require the elaborate oral prep that CTE demands.

CTE earns its keep in a more focused set of scenarios:

Crohn’s disease monitoring: CTE is one of the primary tools for assessing how much of the small bowel is inflamed, whether strictures have formed, and whether the disease is responding to treatment.
Obscure GI bleeding: When upper and lower endoscopy haven’t found the source of bleeding, CTE can identify small-bowel vascular lesions, tumors, or ulcers that are beyond the reach of a standard colonoscope. A systematic review found CTE to be an excellent diagnostic tool in patients with obscure GI bleeding, with particular strength in detecting vascular and inflammatory lesions.⁸
Small bowel strictures: CTE can identify narrowed segments of bowel and measure how much the intestine upstream has dilated, which helps predict the likelihood of future obstruction or need for surgery. A large study of over 1,000 Crohn’s disease patients used CTE measurements to show that patients with strictures, even relatively mild ones, faced roughly double the risk of emergency department visits and were significantly more likely to need surgery.⁹
Small bowel tumors: Primary tumors of the small intestine are uncommon but notoriously hard to find. CTE’s ability to show wall enhancement and subtle masses gives it an advantage over routine CT.

If the clinical question is “what’s going on in this person’s small bowel,” CTE is the right call. If the question is “does this person have appendicitis” or “where has this cancer spread,” a standard CT with positive oral contrast is usually more appropriate. For detecting malignant deposits scattered through the abdomen (peritoneal carcinomatosis, for example), positive oral contrast actually has advantages, because the bright fluid in the bowel helps distinguish tumor implants from normal bowel loops. One study found that adequate bowel filling with positive contrast gave a higher negative predictive value for ruling out malignant deposits compared with neutral contrast.¹⁰

Radiation Exposure and Dose Reduction

Both exams use ionizing radiation, and CTE historically delivered a similar or slightly higher dose than a standard abdominal CT because the protocol demands thin-slice, high-resolution images through the entire abdomen and pelvis. For patients with Crohn’s disease, who may need repeated imaging over years or decades, cumulative radiation is a real concern.

The good news is that scanner technology has improved dramatically. Iterative reconstruction algorithms allow radiologists to cut the radiation dose substantially without losing diagnostic accuracy. One study found that using adaptive statistical iterative reconstruction allowed an average dose reduction of about 35% compared with standard technique.¹¹ A more recent prospective comparison confirmed that low-radiation-dose CTE using model-based iterative reconstruction cut the effective dose roughly in half (from about 7 mSv to about 3 mSv) while maintaining the ability to quantify Crohn’s disease activity.¹² Separately, research has shown that even cutting the dose in half does not compromise CTE’s diagnostic accuracy for detecting active Crohn’s disease in the terminal ileum, which is the most commonly affected site.¹³

How CTE Compares with MR Enterography and Capsule Endoscopy

CTE isn’t the only option for evaluating the small bowel. MR enterography (MRE) uses an MRI machine instead of a CT scanner, with a similar oral prep to distend the bowel. Because MRE uses no ionizing radiation, it’s especially attractive for younger patients and anyone who needs frequent follow-up imaging. A prospective comparison found that MRE and CTE had similar sensitivity for detecting active small-bowel Crohn’s disease (about 91% vs. 95%), though CTE scored higher on image quality.¹⁴ MRE takes longer to perform, is more sensitive to patient motion, and is less widely available, which is why CTE remains the go-to in many emergency and community hospital settings.

Video capsule endoscopy (VCE), the swallowable pill camera, fills a different niche. For suspected small-bowel bleeding, a meta-analysis found that capsule endoscopy was significantly more sensitive than CTE (about 74% vs. 47%), but CTE was far more specific (about 94% vs. 53%).¹⁵ In practical terms, VCE is better at catching mucosal lesions like tiny ulcers and angiodysplasias, while CTE is better at identifying tumors and structural abnormalities like Meckel’s diverticula. A prospective head-to-head study confirmed this pattern and found that combining both tests raised the overall sensitivity to about 89%, significantly higher than either test alone.¹⁶ These tests complement each other rather than compete.

Bonus Findings Outside the Bowel

One underappreciated advantage of CTE is that it scans the entire abdomen and pelvis with high-resolution images, which means it frequently catches things that have nothing to do with the bowel. In one cohort of Crohn’s disease patients undergoing CTE, about 45% had incidental non-IBD findings, including two unsuspected malignancies, though most of these were benign and only about 13% required urgent follow-up.¹⁷ The same study found that roughly 21% of patients had penetrating disease (fistulas, abscesses) and about 19% had extraintestinal manifestations of IBD, such as liver or vascular complications, with the majority of these being new findings that hadn’t been previously recognized.

CTE is also valuable in pediatric patients with Crohn’s disease for mapping both intestinal and extraintestinal involvement, assessing treatment response, and catching complications early.¹⁸ For children, the conversation about radiation dose is even more important, and many pediatric centers now lean toward MRE for routine monitoring while reserving CTE for acute situations where speed and availability matter.

Dual-Energy CT and Where the Technology Is Heading

The newest evolution in CTE involves dual-energy CT scanners, which acquire images at two different X-ray energy levels simultaneously. This lets radiologists create “iodine maps” of the bowel wall, essentially measuring how much IV contrast material has been absorbed by the tissue. In Crohn’s disease, inflamed bowel segments absorb significantly more iodine than normal or quiescent segments. One study comparing dual-energy CTE results with tissue samples taken during surgery found that a simple iodine-density threshold could identify active inflammation with 100% sensitivity and 75% specificity.¹⁹

Beyond simply detecting inflammation, iodine density measurements appear to differ across Crohn’s disease phenotypes. Research has shown that iodine concentration increases with disease severity and changes in a distinct pattern for penetrating disease (fistulas and abscesses) compared with purely inflammatory or stricturing disease.²⁰ And dual-energy iodine maps have been shown to distinguish active Crohn’s disease from remission significantly better than standard CT measurements alone.²¹ This technology is still being refined and isn’t universally available, but it represents a shift toward turning CTE from a qualitative “does this look inflamed?” assessment into a quantitative measurement that could track disease activity over time with more precision.